Results 281 to 290 of about 463,247 (329)
Some of the next articles are maybe not open access.
Current Opinion in Gastroenterology, 2000
There continues to be great interest in Barrett esophagus, the premalignant lesion for adenocarcinoma of the esophagus and the esophagogastric junction. There were several publications this past year related to the epidemiology, pathogenesis, new methods for detection, biomarkers for stratifying patients by risk, and the treatment of patients with ...
P, Sharma, R E, Sampliner
openaire +4 more sources
There continues to be great interest in Barrett esophagus, the premalignant lesion for adenocarcinoma of the esophagus and the esophagogastric junction. There were several publications this past year related to the epidemiology, pathogenesis, new methods for detection, biomarkers for stratifying patients by risk, and the treatment of patients with ...
P, Sharma, R E, Sampliner
openaire +4 more sources
Journal of Gastroenterology and Hepatology, 2011
AbstractBarrett's esophagus is an acquired metaplastic abnormality in which the normal stratified squamous epithelium lining of the esophagus is replaced by an intestinal‐like columnar epithelium. While in itself a benign and asymptomatic disorder, the clinical importance of this relatively common condition relates to its role as a precursor lesion to ...
David I. Watson +4 more
openaire +3 more sources
AbstractBarrett's esophagus is an acquired metaplastic abnormality in which the normal stratified squamous epithelium lining of the esophagus is replaced by an intestinal‐like columnar epithelium. While in itself a benign and asymptomatic disorder, the clinical importance of this relatively common condition relates to its role as a precursor lesion to ...
David I. Watson +4 more
openaire +3 more sources
Current Opinion in Internal Medicine, 2003
The importance of an in-depth understanding about Barrett esophagus is ultimately to decrease the mortality and morbidity from esophageal adenocarcinoma cancer by early detection of metaplasia and dysplasia and appropriate therapy. This review summarizes several publications in the past year related to the epidemiology, pathogenesis, screening and ...
Sanjeev, Slehria, Prateek, Sharma
openaire +2 more sources
The importance of an in-depth understanding about Barrett esophagus is ultimately to decrease the mortality and morbidity from esophageal adenocarcinoma cancer by early detection of metaplasia and dysplasia and appropriate therapy. This review summarizes several publications in the past year related to the epidemiology, pathogenesis, screening and ...
Sanjeev, Slehria, Prateek, Sharma
openaire +2 more sources
Surgical Clinics of North America, 1997
The columnar replacement of squamous epithelium in the lower esophagus is the result of gastroesophageal reflux. Whether the squamous cells are replaced or undergo metaplasia is still conjectural. This neoepithelium is unstable in the presence of continued reflux and prone to complications of stricture, ulceration, and adenocarcinoma.
C G, Bremner, R M, Bremner
openaire +4 more sources
The columnar replacement of squamous epithelium in the lower esophagus is the result of gastroesophageal reflux. Whether the squamous cells are replaced or undergo metaplasia is still conjectural. This neoepithelium is unstable in the presence of continued reflux and prone to complications of stricture, ulceration, and adenocarcinoma.
C G, Bremner, R M, Bremner
openaire +4 more sources
Annals of Internal Medicine, 1982
Barrett's esophagus denotes the presence of columnar epithelium in the esophagus instead of the usual stratified squamous epithelium. Barrett's esophagus had been thought to represent a mediastinal extension of the stomach in patients with a congenital short esophagus.
E M, Bozymski +2 more
openaire +4 more sources
Barrett's esophagus denotes the presence of columnar epithelium in the esophagus instead of the usual stratified squamous epithelium. Barrett's esophagus had been thought to represent a mediastinal extension of the stomach in patients with a congenital short esophagus.
E M, Bozymski +2 more
openaire +4 more sources
Barrett esophagus and risk of esophageal cancer: a clinical review.
Journal of the American Medical Association (JAMA), 2013IMPORTANCE Barrett esophagus, a complication of gastroesophageal reflux disease (GERD), predisposes patients to esophageal adenocarcinoma, a tumor that has increased in incidence more than 7-fold over the past several decades.
S. Spechler
semanticscholar +1 more source
Surgical Clinics of North America, 2015
Although there are many unanswered questions with Barrett esophagus, we can safely say that the incidence is increasing, chemoprevention strategies for the prevention of Barrett metaplasia and its progression to adenocarcinoma may be in the offing, surveillance should be considered for all patients who are discovered to have Barrett esophagus, RFA is ...
Mark, Splittgerber, Vic, Velanovich
openaire +2 more sources
Although there are many unanswered questions with Barrett esophagus, we can safely say that the incidence is increasing, chemoprevention strategies for the prevention of Barrett metaplasia and its progression to adenocarcinoma may be in the offing, surveillance should be considered for all patients who are discovered to have Barrett esophagus, RFA is ...
Mark, Splittgerber, Vic, Velanovich
openaire +2 more sources
Current Treatment Options in Gastroenterology, 2014
Barrett's esophagus (BE) is the most important and recognizable precursor lesion for esophageal adenocarcinoma (EAC), which is the one of the fastest-growing cancers in the Western world (600 % in the U.S. in the last 40 years), and therefore it is critical to manage the risk of cancer present in BE.
Shanmugarajah, Rajendra, Prateek, Sharma
openaire +2 more sources
Barrett's esophagus (BE) is the most important and recognizable precursor lesion for esophageal adenocarcinoma (EAC), which is the one of the fastest-growing cancers in the Western world (600 % in the U.S. in the last 40 years), and therefore it is critical to manage the risk of cancer present in BE.
Shanmugarajah, Rajendra, Prateek, Sharma
openaire +2 more sources
Gastroenterology, 2019
DESCRIPTION The purpose of this best practice advice article is to describe, in patients with Barrett's esophagus (BE) with dysplasia/early cancer, the role of Barrett's endoscopic therapy (BET) and appropriate follow-up of these patients.
Prateek Sharma +3 more
semanticscholar +1 more source
DESCRIPTION The purpose of this best practice advice article is to describe, in patients with Barrett's esophagus (BE) with dysplasia/early cancer, the role of Barrett's endoscopic therapy (BET) and appropriate follow-up of these patients.
Prateek Sharma +3 more
semanticscholar +1 more source
Barrett's esophagus and adenocarcinoma [PDF]
European Journal of Cardio-Thoracic Surgery, 1987 Sixty-two cases of Barrett's esophagus were observed among 707 patients with hiatal hernia (8.7%). The symptomatology of this condition is described. An additional 10 adenocarcinomas were associated with a Barrett's esophagus--a carcinoma prevalence of 13.8%.
E. Mensier, Ribet M, F. R. Pruvot
openaire +5 more sources